TY - JOUR AU - Hanahan, D. AU - Weinberg, R. A. PY - 2000 DA - 2000// TI - The hallmarks of cancer JO - Cell VL - 100 UR - https://doi.org/10.1016/S0092-8674(00)81683-9 DO - 10.1016/S0092-8674(00)81683-9 ID - Hanahan2000 ER - TY - JOUR AU - Satyanarayana, A. AU - Kaldis, P. PY - 2009 DA - 2009// TI - Mammalian cell-cycle regulation: several Cdks, numerous cyclins and diverse compensatory mechanisms JO - Oncogene VL - 28 UR - https://doi.org/10.1038/onc.2009.170 DO - 10.1038/onc.2009.170 ID - Satyanarayana2009 ER - TY - JOUR AU - Lundberg, A. S. AU - Weinberg, R. A. PY - 1998 DA - 1998// TI - Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes JO - Mol Cell Biol VL - 18 UR - https://doi.org/10.1128/MCB.18.2.753 DO - 10.1128/MCB.18.2.753 ID - Lundberg1998 ER - TY - JOUR AU - Dyson, N. PY - 1998 DA - 1998// TI - The regulation of E2F by pRB-family proteins JO - Genes Dev VL - 12 UR - https://doi.org/10.1101/gad.12.15.2245 DO - 10.1101/gad.12.15.2245 ID - Dyson1998 ER - TY - JOUR AU - Sherr, C. J. PY - 1996 DA - 1996// TI - Cancer cell cycles JO - Science VL - 274 UR - https://doi.org/10.1126/science.274.5293.1672 DO - 10.1126/science.274.5293.1672 ID - Sherr1996 ER - TY - JOUR AU - Riabowol, K. AU - Draetta, G. AU - Brizuela, L. AU - Vandre, D. AU - Beach, D. PY - 1989 DA - 1989// TI - The cdc2 kinase is a nuclear protein that is essential for mitosis in mammalian cells JO - Cell VL - 57 UR - https://doi.org/10.1016/0092-8674(89)90914-8 DO - 10.1016/0092-8674(89)90914-8 ID - Riabowol1989 ER - TY - JOUR AU - Furuno, N. AU - den Elzen, N. AU - Pines, J. PY - 1999 DA - 1999// TI - Human cyclin A is required for mitosis until mid prophase JO - J Cell Biol VL - 147 UR - https://doi.org/10.1083/jcb.147.2.295 DO - 10.1083/jcb.147.2.295 ID - Furuno1999 ER - TY - JOUR AU - Sherr, C. J. AU - Roberts, J. M. PY - 1999 DA - 1999// TI - CDK inhibitors: positive and negative regulators of G1-phase progression JO - Genes Dev VL - 13 UR - https://doi.org/10.1101/gad.13.12.1501 DO - 10.1101/gad.13.12.1501 ID - Sherr1999 ER - TY - JOUR AU - Ortega, S. AU - Malumbres, M. AU - Barbacid, M. PY - 2002 DA - 2002// TI - Cyclin D-dependent kinases, INK4 inhibitors and cancer JO - Biochim Biophys Acta VL - 1602 ID - Ortega2002 ER - TY - JOUR AU - Kim, J. K. AU - Diehl, J. A. PY - 2009 DA - 2009// TI - Nuclear cyclin D1: an oncogenic driver in human cancer JO - J Cell Physiol VL - 220 UR - https://doi.org/10.1002/jcp.21791 DO - 10.1002/jcp.21791 ID - Kim2009 ER - TY - JOUR AU - Mermelshtein, A. AU - Gerson, A. AU - Walfisch, S. AU - Delgado, B. AU - Shechter-Maor, G. AU - Delgado, J. AU - Fich, A. AU - Gheber, L. PY - 2005 DA - 2005// TI - Expression of D-type cyclins in colon cancer and in cell lines from colon carcinomas JO - Br J Cancer VL - 93 UR - https://doi.org/10.1038/sj.bjc.6602709 DO - 10.1038/sj.bjc.6602709 ID - Mermelshtein2005 ER - TY - JOUR AU - Malumbres, M. AU - Barbacid, M. PY - 2009 DA - 2009// TI - Cell cycle, CDKs and cancer: a changing paradigm JO - Nat Rev Cancer VL - 9 UR - https://doi.org/10.1038/nrc2602 DO - 10.1038/nrc2602 ID - Malumbres2009 ER - TY - STD TI - Cole AM, Myant K, Reed KR, Ridgway RA, Athineos D, Van den Brink GR, Muncan V, Clevers H, Clarke AR, Sicinski P, Sansom OJ: Cyclin D2-cyclin-dependent kinase 4/6 is required for efficient proliferation and tumorigenesis following Apc loss.Cancer Res70: 8149–8158. 10.1158/0008-5472.CAN-10-0315 ID - ref13 ER - TY - JOUR AU - Sansom, O. J. AU - Reed, K. R. AU - Hayes, A. J. AU - Ireland, H. AU - Brinkmann, H. AU - Newton, I. P. AU - Batlle, E. AU - Simon-Assmann, P. AU - Clevers, H. AU - Nathke, I. S. PY - 2004 DA - 2004// TI - Loss of Apc in vivo immediately perturbs Wnt signaling, differentiation, and migration JO - Genes Dev VL - 18 UR - https://doi.org/10.1101/gad.287404 DO - 10.1101/gad.287404 ID - Sansom2004 ER - TY - JOUR AU - Sansom, O. J. AU - Meniel, V. S. AU - Muncan, V. AU - Phesse, T. J. AU - Wilkins, J. A. AU - Reed, K. R. AU - Vass, J. K. AU - Athineos, D. AU - Clevers, H. AU - Clarke, A. R. PY - 2007 DA - 2007// TI - Myc deletion rescues Apc deficiency in the small intestine JO - Nature VL - 446 UR - https://doi.org/10.1038/nature05674 DO - 10.1038/nature05674 ID - Sansom2007 ER - TY - JOUR AU - Bouchard, C. AU - Thieke, K. AU - Maier, A. AU - Saffrich, R. AU - Hanley-Hyde, J. AU - Ansorge, W. AU - Reed, S. AU - Sicinski, P. AU - Bartek, J. AU - Eilers, M. PY - 1999 DA - 1999// TI - Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27 JO - Embo J VL - 18 UR - https://doi.org/10.1093/emboj/18.19.5321 DO - 10.1093/emboj/18.19.5321 ID - Bouchard1999 ER - TY - JOUR AU - Eilers, M. PY - 1999 DA - 1999// TI - Control of cell proliferation by Myc family genes JO - Mol Cells VL - 9 ID - Eilers1999 ER - TY - STD TI - Athineos D, Sansom OJ: Myc heterozygosity attenuates the phenotypes of APC deficiency in the small intestine.Oncogene29: 2585–2590. 10.1038/onc.2010.5 ID - ref18 ER - TY - JOUR AU - Sansom, O. J. AU - Reed, K. R. AU - van de Wetering, M. AU - Muncan, V. AU - Winton, D. J. AU - Clevers, H. AU - Clarke, A. R. PY - 2005 DA - 2005// TI - Cyclin D1 is not an immediate target of beta-catenin following Apc loss in the intestine JO - J Biol Chem VL - 280 UR - https://doi.org/10.1074/jbc.M500191200 DO - 10.1074/jbc.M500191200 ID - Sansom2005 ER - TY - JOUR AU - Wilding, J. AU - Straub, J. AU - Bee, J. AU - Churchman, M. AU - Bodmer, W. AU - Dickson, C. AU - Tomlinson, I. AU - Ilyas, M. PY - 2002 DA - 2002// TI - Cyclin D1 is not an essential target of beta-catenin signaling during intestinal tumorigenesis, but it may act as a modifier of disease severity in multiple intestinal neoplasia (Min) mice JO - Cancer Res VL - 62 ID - Wilding2002 ER - TY - JOUR AU - Wang, L. AU - Wang, J. AU - Blaser, B. W. AU - Duchemin, A. M. AU - Kusewitt, D. F. AU - Liu, T. AU - Caligiuri, M. A. AU - Briesewitz, R. PY - 2007 DA - 2007// TI - Pharmacologic inhibition of CDK4/6: mechanistic evidence for selective activity or acquired resistance in acute myeloid leukemia JO - Blood VL - 110 UR - https://doi.org/10.1182/blood-2007-02-071266 DO - 10.1182/blood-2007-02-071266 ID - Wang2007 ER - TY - JOUR AU - Fry, D. W. AU - Harvey, P. J. AU - Keller, P. R. AU - Elliott, W. L. AU - Meade, M. AU - Trachet, E. AU - Albassam, M. AU - Zheng, X. AU - Leopold, W. R. AU - Pryer, N. K. AU - Toogood, P. L. PY - 2004 DA - 2004// TI - Specific inhibition of cyclin-dependent kinase 4/6 by PD 0332991 and associated antitumor activity in human tumor xenografts JO - Mol Cancer Ther VL - 3 ID - Fry2004 ER - TY - STD TI - Hung KE, Maricevich MA, Richard LG, Chen WY, Richardson MP, Kunin A, Bronson RT, Mahmood U, Kucherlapati R: Development of a mouse model for sporadic and metastatic colon tumors and its use in assessing drug treatment.Proc Natl Acad Sci USA107: 1565–1570. 10.1073/pnas.0908682107 ID - ref23 ER - TY - JOUR AU - Marsh, V. AU - Winton, D. J. AU - Williams, G. T. AU - Dubois, N. AU - Trumpp, A. AU - Sansom, O. J. AU - Clarke, A. R. PY - 2008 DA - 2008// TI - Epithelial Pten is dispensable for intestinal homeostasis but suppresses adenoma development and progression after Apc mutation JO - Nat Genet VL - 40 UR - https://doi.org/10.1038/ng.256 DO - 10.1038/ng.256 ID - Marsh2008 ER -